TriSalus Life Sciences, Inc.

TLSI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$8,525$11,777$9,414$30,301
Short-Term Investments$0$0$0$0
Receivables$5,087$3,554$1,557$1,357
Inventory$4,048$2,545$1,471$1,292
Other Curr. Assets$3,009$2,986$4,772$2,181
Total Curr. Assets$20,669$20,862$17,214$35,131
Property Plant & Equip (Net)$2,879$3,270$3,612$1,797
Goodwill$0$0$0$0
Intangibles$0$0$802$794
Long-Term Investments$350$0$250$0
Tax Assets$0$0$0$0
Other NC Assets$73$466$117$115
Total NC Assets$3,302$3,736$4,781$2,706
Other Assets$0$0$0$0
Total Assets$23,971$24,598$21,995$37,837
Liabilities
Payables$2,274$3,391$4,947$1,300
Short-Term Debt$216$351$370$0
Tax Payable$34$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$7,704$10,945$27,040$5,073
Total Curr. Liab.$10,228$14,687$32,357$6,373
LT Debt$23,413$1,244$1,593$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$16,224$35,732$369$561
Total NC Liab.$39,637$36,976$1,962$561
Other Liabilities$0$0$0$0
Cap. Leases$1,545$1,595$1,593$0
Total Liabilities$49,865$51,663$34,319$6,934
Equity
Pref Stock$0$0$164,006$160,507
Common Stock$3$2$0$11
Retained Earnings-$279,549-$249,504-$186,358-$136,342
AOCI$0-$0$0$0
Other Equity$253,652$222,437$10,028$6,727
Total Equity-$25,894-$27,065-$12,324$30,903
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$23,971$24,598$21,995$37,837
Net Debt$15,104-$10,182-$7,451-$30,301